Background-Recent genome-wide association studies have identified common variants associated with high-density lipoprotein cholesterol (HDL-C). Whether these associations are modified by physical activity, which increases HDL-C levels and reduces the risk of cardiovascular disease, is uncertain. Methods and Results-In a prospective cohort study of 22 939 apparently healthy US women of European ancestry, we selected 58 single nucleotide polymorphisms (SNPs) in 9 genes that demonstrated genome-wide association (PϽ5ϫ10 Ϫ8 ) with HDL-C levels and sought evidence of effect modification according to levels of physical activity. Physical activity modified the effects on HDL-C of 7 SNPs at 3 loci, and the strongest evidence of effect was observed for rs10096633 at lipoprotein lipase (LPL), rs1800588 at hepatic lipase (LIPC), and rs1532624 at cholesteryl ester transfer protein (CETP) (each P-interaction Ͻ0.05). The per-minor-allele increase in HDL-C for rs1800588 at LIPC and rs1532624 at CETP was greater in active than inactive women, whereas the reverse was observed for rs10096633 at LPL. Minor-allele carrier status at the LPL SNP was associated with a reduced risk of myocardial infarction in active (hazard ratio, 0.51; 95% confidence interval 0.30 -0.86) but not among inactive women (hazard ratio 1.13; 95% confidence interval 0.79 to 1.61; P-interactionϭ0.007). By contrast, carrier status at the CETP SNP was associated with a reduced risk of myocardial infarction regardless of activity level (hazard ratio, 0.72; 95% confidence interval, 0.57 to 0.92; P-interactionϭ0.71). No association between LIPC SNP carrier status and myocardial infarction risk was noted. Conclusions-The effects of common variants in the LPL, LIPC, and CETP genes on HDL-C levels are modified by physical activity. For a common variant in LPL, the impact on myocardial infarction varied by activity level, whereas the effects of a common variant in CETP on myocardial infarction risk did not. (Circ Cardiovasc Genet. 2011;4:74-80.)
P rospective cohort studies demonstrate a strong inverse relationship between high-density lipoprotein cholesterol (HDL-C) and risk of cardiovascular disease. 1 HDL-C levels are highly heritable and recent genome-wide association studies have identified single nucleotide polymorphisms (SNPs) in at least 9 genes that alter HDL-C levels. [2] [3] [4] [5] [6] Although some studies have demonstrated an association between SNPs associated with HDL-C levels and the risk of future cardiovascular events, others have not. 6 -12 
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Environmental factors also contribute to the variation observed in HDL-C levels. Physical activity is associated with higher levels of HDL-C in several epidemiological studies, [13] [14] [15] and variation in the cholesteryl ester transfer protein (CETP), hepatic lipase (LIPC), apolipoprotein (APO)A1, LIPG, APOE, and lipoprotein lipase (LPL) genes have been reported to contribute to interindividual variability in the HDL-C response to exercise. 16 -23 The extent to which regular physical activity modifies the effect of recently discovered SNPs on HDL-C levels, or their effect on risk of myocardial infarction (MI), has not been well studied, particularly among women.
We sought to determine whether associations between common SNPs and HDL-C levels are modified by physical activity in a large cohort of healthy US women of European ancestry. Additionally, to examine the clinical implications of our findings, we investigated whether favorable genotypes at significant loci are associated with lowered risk of MI and if this risk is modified by level of physical activity. Study (WHS). 24 Study participants in the WHS were female health professionals ages 45 years and older at the time of enrollment who were free of any major chronic disease including cancer and cardiovascular disease at study entry (1992 to 1995) . Information on baseline variables including race/ethnicity, demographic characteristics, medical history, medications, and dietary and lifestyle facts were reported on questionnaires. The Women's Genome Health Study includes 23 294 women of European ancestry who consented to ongoing analyses using genetic data and for whom we have baseline plasma and DNA. We used all 23 294 women in our initial SNP screening step and then restricted our sample to the 22 939 women for whom we also had information on physical activity and HDL-C. The study was approved by the institutional review board of the Brigham and Women's Hospital (Boston, MA).
Genotyping and SNP Selection
DNA samples were genotyped with the Infinium II technology from Illumina (Human HAP300 panel), as previously described. 24 All samples were required to have successful genotyping using the BeadStudio v. 3.3 software (Illumina, San Diego, CA) for at least 98% of the SNPs. SNPs with call rates Ͻ90% and with a minor allele frequency Ͻ1% in participants of European ancestry were removed from the analysis. SNPs were evaluated for deviation from Hardy-Weinberg equilibrium using an exact method and were excluded when the probability value was lower than 10 Ϫ6 . After quality control, a total of 339 596 SNPs were left for the analysis. Genotyping success at SNPs used for our analysis ranged from 97% at rs1532624 to Ͼ99.99% at rs10096633 and rs1800588.
Physical Activity
At baseline, each participant was asked to report her approximate average time per week during the previous year spent on 8 groups of recreational activities (walking/hiking, jogging, running, bicycling, aerobic exercise/dance, lap swimming, tennis/squash/racquetball, and lower-intensity exercise) and the number of flights of stairs climbed on a questionnaire previously shown to be both valid and reliable. 25, 26 A metabolic equivalent (MET) score was assigned to each activity based on the energy cost of that activity and the energy expended on each activity was then estimated by multiplying its MET score with hours per week and summed across all activities (MET-hours/wk). The United States Government recommends at least 150 minutes per week of moderate-intensity aerobic activity (eg, brisk walking), the equivalent of Ն7.5 MET-hours/wk. 27
Lipid Assessment
EDTA blood samples were obtained at the time of enrollment in the WHS and stored in vapor-phase liquid nitrogen (Ϫ170°C). Study participants had baseline blood samples assayed for HDL-C, ApoA1, and triglyceride (TG) levels in a core laboratory certified by the National Heart, Lung, and Blood Institute/Centers for Disease Control and Prevention Lipid Standardization Program and had low coefficients of variance. 4 Among the 21 806 women for whom we have information on fasting status, 16 562 (76%) were fasting for at least 8 hours before blood collection.
Ascertainment of Cardiovascular Events
Criteria for end point assessment have been reported previously. 28 All study participants were followed for myocardial infarction through February 2008. An end-points committee of physicians reviewed medical records for all participants reporting MI. Events were confirmed if symptoms met World Health Organization Criteria and if the event was associated with abnormal levels of cardiac enzymes or diagnostic ECG criteria. Only confirmed end points were included in this analysis.
Statistical Analysis
We identified the common SNPs in 9 previously described genes 3, 6 influencing HDL-C levels at a genome-wide level of statistical significance (PϽ5ϫ10 Ϫ8 ) in the 23 294 women for whom we have genotype information by performing linear regression in PLINK. In total, 58 SNPs achieved genome-wide significance for HDL-C (online-only Data Supplement Table 1 ). All 58 SNPs were screened for statistically significant evidence of effect modification by physical activity across the median in our cohort (8.8 MET-hours/wk), using the unadjusted quantitative trait interaction procedure available in PLINK. 29 An a priori threshold of PϽ0.05 was used to select SNPs for further analysis. A sensitivity analysis using physical activity adjusted HDL-C levels identified 5 additional SNPs, 2 of which were in a tenth gene (LCAT) that was not identified in the primary analysis but which has been identified previously as a determinant of HDL-C. 6 These 5 SNPs were also tested for evidence of effect modification.
After restricting the sample to those with complete information for HDL-C and MET-hours of physical activity (nϭ22 939), characteristics of the study population were computed across the physical activity median in our cohort (8.8 MET-hours/wk) and compared using 2-sided t tests for continuous variables and 2 tests for categorical variables. We performed a multivariable linear regression analyses for each significant SNP, assuming an additive model of inheritance, to test the association with HDL-C levels after adjustment for age, body mass index (BMI), alcohol intake, hypertension, diabetes, and hormone use status. We calculated the effect estimates and mean levels of HDL-C for each genotype at each selected SNP, stratified by median activity levels. Tests for interaction were performed using multivariable linear regression models that included the above covariates, number of copies of the minor allele at each SNP (0, 1, or 2), physical activity below (0) and above (1) the median, and an interaction term (SNP*physical activity). We tested the significant SNPs for evidence of effect modification of ApoA1 levels, the major apolipoprotein on the HDL-C molecule, in similarly adjusted models. As a sensitivity analysis, we used a P-value threshold of 0.0056, which represents a P-value threshold of 0.05 corrected for the 9 genes tested for evidence of interaction.
We created 3 separate genotype scores, 1 for each SNP (rs10096633 in LPL, rs1800588 in LIPG, and rs1532624 in CETP). At each SNP, we used a dominant model to categorize women into 2 groups: those who were homozygous for the major allele and those who were carriers of a minor allele. At rs10096633, rs1800588, and rs1532624, women homozygous for the major allele had lower HDL-C levels than women carrying at least 1 copy of the minor allele, and thus were defined as having a "deleterious" genotype. Minor allele carrier status was defined as "beneficial" for each of these 3 SNPs on the assumption that any impact on MI risk would be consistent with the observed effect on HDL-C. We used multivariable Cox proportional hazard models, adjusting for age, BMI, blood pressure (Framingham categories), history of diabetes, smoking, and total cholesterol, to estimate the hazard ratio (HR) of incident MI in the entire cohort associated with each genotype score. Next, we performed a stratified analysis, according to genotype score, to estimate the HR of incident MI associated with increased level physical activity, using inactive women (Յ8.8 MET-hours/wk, the median in our cohort) as the reference group.
All analyses were carried out using SAS/Genetics 9.1 package (SAS Institute Inc, Cary, NC) and PLINK. 29
Results
Women who reported physical activity levels above the median of 8.8 MET-hours/wk had, on average, a lower baseline BMI, lower TG levels, higher levels of HDL-C and ApoA1, and a lower prevalence of self-reported diabetes and hypertension (Table 1) . Postmenopausal hormone use and moderate alcohol use was also more common among more active women.
The SNPs associated with HDL-C levels at a genome-wide level of statistical significance and their unadjusted probability values for interaction with the median level of physical activity (8.8 MET-hours/wk) are displayed in online-only Data Supplement Table 1 , sorted by chromosomal position. Evidence of effect modification was observed for 8 SNPs in 4 genes, including 2 SNPs at LPL (8q21), 3 at LIPC (15q22), 2 at CETP (16q13), and 1 at LIPG (18q45). The SNPs with the smallest interaction probability value at each locus were rs10096633 (LPL; P-interactionϭ0.006), rs1800588 (LIPC; P-interactionϭ 0.01), rs1532624 (CETP; P-interactionϭ0.008), and rs4939883 (LIPG; P-interactionϭ0.03). The absolute difference (SE) in HDL-C level per copy of each significant allele ranged from 1.098 (0.193) for rs4939883 in LIPG (minor allele frequencyϭ 0.17) to 3.067 (0.146) for rs1532624 in CETP (minor allele frequencyϭ0.43). We did not observe evidence of effect modification for other SNPs with similar minor allele frequency and effect sizes (online-only Data Supplement Table 1 ). None of the 5 SNPs identified in a sensitivity analysis using physical activity adjusted HDL-C met the prespecified criteria for evidence of effect modification (online-only Data Supplement Table 2 ).
Mean (ϮSD) HDL-C by genotype and increase in HDL-C per copy of the minor alleles at significant SNPs within the LPL, LIPC, CETP, and LIPG genes in all women and in women stratified by median levels of physical activity are displayed in Table 2 . As shown, we observed a smaller per-allele increase in HDL-C for rs10096633 at LPL among active women (1.0 mg/dL per copy) than among inactive women (2.1 mg/dL per copy, P-interactionϭ0.004). By contrast, for rs1532624 at CETP and rs1800588 at LIPC, we observed a larger increase in HDL-C levels per copy of the minor allele in active women than in inactive women (P-interactionϭ0.04 and 0.02, respectively). Although our initial test for interaction suggested that the effect of rs4939883 at LIPG on HDL-C levels was modified by physical activity, this effect was no longer statistically significant in the fully adjusted model. Similar results were seen for the SNPs in LPL, LIPC, and CETP when using an alternative physical activity cut-point (online-only Data Supplement Table 3 ). The distribution of HDL-C levels stratified by genotype and physical activity level are presented in the online-only Data Supplement Figure. The proportion of variance in HDL-C explained by the physical activity-genotype interaction was 0.03% for rs10096633 in LPL, 0.01% for rs1800588 in LIPC, and 0.03% for rs1532624 in CETP. By comparison, adding of each SNP individually to adjusted models explained an additional 0.27% (rs10096633), 0.58% (rs1800588), or 1.99% (rs1532624) of the variance in HDL-C. In sensitivity analyses using a P-value threshold corrected for the number of genes analyzed (PϽ0.0056), evidence of interaction remained statistically significant only for rs10096633 in LPL. When we restricted our analysis to women who had been fasting for at least 8 hours at the time of blood collection, our observations did not differ substantially.
We observed similar associations between the above SNPs and ApoA1 levels ( Table 3 ). As seen with HDL-C, the observed per-allele increase in ApoA1 for rs10096633 at LPL Test for interaction 0.14 was greater among inactive women (P-interaction Ͻ0.001).
Copies of the minor allele at rs1532624 (CETP) and rs1800588 (LIPC) were associated with a greater increases in ApoA1 levels among active women, compared with inactive women (P-interactionϭ0.02 and 0.09, respectively).
Higher HDL-C levels were observed among women with the beneficial as compared with deleterious genotype at rs10096633 in LPL (55.08 versus 53.33 mg/dL, PϽ0.0001), rs1800588 at LIPC (55.17 versus 52.87 mg/dL, PϽ0.0001), and rs1532624 at CETP (54.99 versus 51.26 mg/dL, PϽ0.0001). However, only women who carried at least 1 copy of the minor allele at CETP had a reduced risk of MI (HR, 0.72; 95% confidence interval [CI], 0.57 to 0.92; Pϭ0.009) after adjusting for age, BMI, diabetes, blood pressure, current smoking, and total cholesterol. Women with a beneficial genotype at rs10096633 (LPL) or rs1800588 (LIPC) were not at reduced risk of MI (LPL: HR, 0.81; 95% CI, 0.61 to 1.09; Pϭ0.16; LIPC: HR, 1.11; 95% CI, 0.87 to 1.41; Pϭ0.39).
The fully adjusted risks of MI for each of the 4 categories of genotype score and activity level are presented in the Figure. As shown in Figure A , compared with inactive women with a deleterious genotype at LPL, active carriers of at least 1 copy of the minor allele at rs10096633 were at reduced risk of MI (HR, 0.51; 95% CI, 0.30 to 0.86; Pϭ0.01). By contrast, inactive women with the beneficial genotype at LPL were not at reduced risk of MI (HR, 1.13; 95% CI, 0.79 to 1.61; Pϭ0.50; P-interactionϭ0.007). The effect of physical activity on MI risk did not appear to be modified by genotype score at rs1800588 (LIPC) (P-interactionϭ0.71, Figure B ). Finally, the reduction in risk associated with a beneficial genotype at rs1532624 at CETP appeared to be similar in active and inactive women, regardless of physical activity level (P-interactionϭ0.71, Figure C ).
Discussion
In this study of 22 939 healthy US women of European ancestry, we report that the effects of SNPs at LPL, LIPC, and CETP on HDL-C levels are modified by physical activity. In our study, the per-allele increase in HDL-C for rs1800588 at LIPC and rs1532624 at CETP was greater among active women, whereas the per-allele increase in HDL-C per copy of the minor allele of rs10096633 at LPL was larger among inactive women. Although minor allele carrier status at each of these loci was associated with higher levels of HDL-C, the associated reduction in risk of MI differed by SNP and by activity level. Minor allele carrier status at LPL was related to a 50% risk reduction in MI only among active participants, and, whereas carrier status at LIPC did not appear to afford protection from risk of MI, the carrier status at CETP was associated with approximately a 30% risk reduction in MI, regardless of activity levels.
We believe these data are of interest for several reasons. First, using a different study design and analytic approach than previous work in the field, we offer further evidence of the established role of LPL, LIPC, and CETP in modulating the response of HDL-C and ApoA1 to physical activity. Prior work has recognized that exercise-induced changes in lipid phenotypes, such as an increase in HDL-C, are related to decreases in plasma levels and activity of CETP, 30, 31 increases in LPL activity in both plasma and skeletal muscle, 20, 32, 33 and to decreases in postheparin plasma LIPC activity. 34 Several studies have shown that genetic variation within CETP can modulate alterations in HDL-C due to exercise, possibly via a differential response of CETP activity or mass to exercise. 12, 18, 19, 35 Other studies have reported that physical activity modifies the effect of 2 common genetic polymorphisms in LPL on HDL-C. 20, 36 Although common variation in LIPC is known to affect enzyme activity, 37 evidence that physical activity modifies the effects of genetic variation in LIPC on plasma LIPC activity and lipid phenotypes is inconsistent. 21, 34, 38 Although our findings also implicate LPL, LIPC, and CETP as important mediators of the response in HDL-C to physical activity, we extend those findings to women, who were absent from many the prior studies. 20, 35, 38 We also measured leisure-time physical activity, which may be less likely to cause substantial charges in lipid metabolism and HDL-C levels than prescribed diet and exercise interventions, which were used in much of the previous work in this area. 18, 19, 21, 34 Second, the magnitude of the per-allele effect of common polymorphisms on HDL-C levels varies according to level of physical activity. For example, the effect of variation at rs10096633 in LPL on HDL-C level is larger among sedentary than active women, whereas the effect of variation at rs1532624 in CETP on HDL-C levels is smaller among sedentary than active women. This differential modification provides a possible biological explanation for the wide variability in HDL-C response to exercise and for the clinical observation that some individuals do not have improvements in HDL-C level despite adopting an exercise regimen. 17 Third, in contrast to rs1532624 at CETP, we report a lack of association between beneficial genotypes at rs10096633 in LPL and rs1800588 at LIPC and risk of incident MI. This is despite that women with at least 1 copy of the minor allele at either locus had HDL-C levels that were, on average, 1.75 to 2.3 mg/dL higher than those with a deleterious genotype score at those loci. This lack of association, when viewed in the context of a strong association between CETP genotype and MI risk in our cohort 7 and others, 12 highlights the understanding that increases in HDL-C levels due to variation in key lipid metabolism genes do not necessarily lead to the expected reduction in vascular risk. 9, 10, 39, 40 Our observation that regular physical activity reduces MI risk among women with a beneficial LPL genotype but not among those with a deleterious genotype raises the additional possibility that the effects of lifestyle choices on cardiovascular events may vary by genotype. Although 1 other study has reported evidence that physical activity alters the vascular risk conferred by the Ϫ480CϾT mutation in LIPC, this report is the first of which we are aware that the effects of physical activity may differ according to variation within LPL. 10 The biological mechanism by which physical activity might reduce the risk of MI among female carriers but not among noncarriers of the minor allele at rs10096633 is unclear. The identity and biological action of the true causal variant are unknown (it is unlikely to be rs10096633), as are the mechanisms by which it might alter LPL levels and/or function, HDL-C levels and/or function, and downstream vascular risk. Although it is certainly possible that altered LPL catalyzes important functional changes in HDL-C that then affect MI risk, the design of the WHS prevents us from being able to tease out whether functional changes in HDL-C or another biological process is the cause of the observed differences in MI risk.
Strengths and Limitations
Strengths of the present study include its large sample size and the careful collection of physical activity data at the time of blood sampling. However, a number of limitations must be considered. First, our analytic approach selected only those SNPs related to HDL-C levels at a Bonferroni-corrected genome-wide level of significance (PϽ5ϫ10 Ϫ8 ). This approach and CETP (C) loci. Women with at least 1 copy of the minor allele at each locus were defined as having a beneficial genotype at that locus, whereas those homozygous for the major allele were defined as having a deleterious genotype at that locus. Compared with those with a deleterious genotype score, HDL-C levels among those with a beneficial genotype score at LPL (rs10096633) were 1.75 mg/dL higher, at LIPC (rs1800588) were 2.3 mg/dL higher, and at CETP (rs1800588) were 3.73 mg/dL higher (each PϽ0.0001).
would not detect genes that had opposite per-allele effects in the 2 strata of physical activity, although the biological plausibility of such an interaction with a continuous exposure such as physical activity is uncertain. Second, although our sample size is large, our power to detect statistically significant interactions is dependent on allele effect size and minor allele frequency. Third, physical activity, weight, height, diabetes, and hypertension were assessed by self-report. Imprecise reporting of the variables may have occurred; however, any misclassification of this kind would be expected to bias the results toward the null because reports were prospective and predated the occurrence of MI. Last, our study only includes participants of European ancestry, and may not be generalizable to other groups.
We believe that the evidence of effect modification reported here is real, in part because the 3 reported loci have been implicated in prior reports of effect modification. In conjunction with findings from previously published work, these findings support the hypothesis that genetic determinants of key steps in HDL-C metabolism, involving the LPL, LIPC, and CETP genes, are differentially modified by physical activity. Finally, our data raise the possibility that the effects of common variants in these genes on MI risk may also be modified by activity level.
Conclusion
In summary, we report evidence that the effects of common polymorphisms in the LPL, LIPC, and CETP genes on HDL-C levels are modified by physical activity. We observed greater per-minor-allele increases in HDL-C for rs1800588 in LIPC and rs1532624 in CETP among active than inactive women and smaller per-allele increases in HDL-C for rs10096633 at LPL among active than inactive women. Minor allele carrier status at LPL was related to risk reduction in MI only among active participants, whereas carrier status at CETP was associated with reductions in risk of MI, regardless of activity status. Minor allele carrier status at LIPC did not appear to associate with MI risk. Common variation within these genes appears to influence the response of HDL-C to physical activity. The protection from MI afforded by higher plasma levels of HDL-C may depend both on absolute levels and variation in the genetic determinants of those levels.
